当前位置: X-MOL 学术Int. J. Dev. Neurosci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
X-linked Adrenoleukodystrophy: Pathology, Pathophysiology, Diagnostic Testing, Newborn Screening, and Therapies
International Journal of Developmental Neuroscience ( IF 1.7 ) Pub Date : 2020-01-26 , DOI: 10.1002/jdn.10003
Bela R Turk 1 , Christiane Theda 2 , Ali Fatemi 1 , Ann B Moser 1
Affiliation  

Adrenoleukodystrophy (ALD) is a rare X‐linked disease caused by a mutation of the peroxisomal ABCD1 gene. This review summarizes our current understanding of the pathogenic cell‐ and tissue‐specific roles of lipid species in the context of experimental therapeutic strategies and provides an overview of critical historical developments, therapeutic trials and the advent of newborn screening in the USA. In ALD, very long‐chain fatty acid (VLCFA) chain length‐dependent dysregulation of endoplasmic reticulum stress and mitochondrial radical generating systems inducing cell death pathways has been shown, providing the rationale for therapeutic moiety‐specific VLCFA reduction and antioxidant strategies. The continuing increase in newborn screening programs and promising results from ongoing and recent therapeutic investigations provide hope for ALD.

中文翻译:


X连锁肾上腺脑白质营养不良:病理学、病理生理学、诊断测试、新生儿筛查和治疗



肾上腺脑白质营养不良 (ALD) 是一种罕见的 X 连锁疾病,由过氧化物酶体 ABCD1 基因突变引起。这篇综述总结了我们目前在实验治疗策略背景下对脂质种类的致病细胞和组织特异性作用的理解,并概述了关键的历史发展、治疗试验和美国新生儿筛查的出现。在 ALD 中,内质网应激和线粒体自由基生成系统存在诱导细胞死亡途径的极长链脂肪酸 (VLCFA) 链长度依赖性失调,这为治疗部分特异性 VLCFA 减少和抗氧化策略提供了理论基础。新生儿筛查项目的持续增加以及正在进行和最近的治疗研究的有希望的结果为 ALD 带来了希望。
更新日期:2020-01-26
down
wechat
bug